None listed
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Among men and women diagnosed with Parkinson's disease, those with a score of 24 or higher on MMSE (Cognitive Function and Dementia Test) 2) Those who fall under the 1st to 3rd level of Hoehn and Yahr Scale *Use a scale of 1 to 5 as the degree of dysfunction in Parkinson's disease. - Stage 1: Symptoms appear on only one side of the trunk. - Stage 2: Symptoms appear on both sides of the trunk, and there is no disturbance of balance. - Stage 3: Balance is impaired. There is a mild degree of progression and is physically dependent. - Stage 4: Severe dysfunction is present, but it is still possible without assistance in walking or standing. - Stage 5: Reliance on a wheelchair or living in bed and having difficulty in activities without assistance 3) A person who has no problem with cognitive function, and who has voluntarily decided to participate in the study after hearing and fully understanding the detailed explanation of this study and consented to participate in the study through written consent
Exclusion criteria
Exclusion criteria: 1) In case of accompanying neurological disease other than Parkinson's disease, such as dementia, Huntington's disease, hydrocephalus 2) In case of gait disturbance due to stroke, brain tumor, or other brain disease 3) In case it is judged inappropriate by the judgment of other researchers 4) Those with a score of 23 or less on the MMSE (Cognitive Function and Dementia Test)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Unified Parkinson's disease rating scale;Non-Motor Symptoms Scale for Parkinson's Disease;EQ-5D | — |
Secondary
| Measure | Time frame |
|---|---|
| Functional near-infrared spectroscopy;Qualitative evaluation of the results of art activities | — |
Countries
Korea, Republic of
Contacts
Daejeon Korean Medicine Hospital of Daejeon University